Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Short Candidates -- Ignore unavailable to you. Want to Upgrade?

To: SouthFloridaGuy who wrote (67)	6/27/2001 9:58:49 AM
From: tuck	Read Replies (3) \| Respond to of 897

Here's a scam in the making to keep an eye on; should it get anywhere, we can short it to oblivion: >>ORLANDO, Fla., June 27 /PRNewswire/ -- AuctionAnything.com, Inc. (OTC Bulletin Board: UBUY - news) announced today that it intends to change its corporate name from AuctionAnything.com, Inc. to Disease Sciences, Inc. On May 25, 2001, the Company announced it had acquired Disease S.I., Inc., a development stage Biotech company researching mad-cow disease, by agreeing to issue common stock totaling 60,000,000 shares as consideration for the acquisition. In connection with the acquisition, the Company determined to adopt the name Disease Sciences, Inc. in order to more accurately reflect its new core business. The name change to Disease Sciences from AuctionAnything.com Inc., is expected to occur sometime during the next 30 days. Additionally, effective with the name change the Company's stock symbol will also change. Upon receipt of the new symbol an announcement will be made to notify shareholders. About Disease S.I. Inc. Disease Sciences, Inc. is a developmental stage biopharmaceutical/clinical diagnostics Company planning to employ a broad array of technologies to detect, identify and quantify substances in blood or other bodily fluids and tissues. Its primary goal will be a Transmissible Spongiform Encephalopathy (``TSE'') test, useful in the diagnosis of TSE diseases such as Bovine Spongiform Encephalopathy (``BSE'') in cattle, (commonly known as ``mad-cow disease''), Scrapie in sheep, Chronic Wasting Disease (``CWD'') in wild deer and elk and Creutzfeldt-Jakob Disease (``CJD'') in humans. Test results are to be used in the diagnosis, detection, evaluation, monitoring and potential treatment of diseases and other medical conditions. The Company intends to derive its revenues from patent sub-licensing fees, royalties from pharmaceutical sales, appropriate milestone payments and research and development contracts. The Company maintains a website at www.diseasesciences.com.<< snip Cheers, Tuck